International Induced Pluripotent Stem Cell (iPSC) Market Report 2021: Focus on Drug Discovery & Toxicity Studies, Academic Research, Cell and Gene Therapy, Regenerative Medicine - Forecast to 2030
Report on the Production of Pluripotent Stem Cell (IPSC) Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change has been added to the report. ResearchAndMarkets.com is the company of Research AndMarket. I'm offering you a plan.
This report provides the strategists, marketers and senior managers with critical information they need to evaluate the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut-down. This report describes and explains the induced pluripotent stem cell (iPSC) market and covers the entire period from 2015 to 2020, the historic period, and the forecast period for the period 2025-2030 as well as The global induced puripotent stem cell (iPSC) market reached a total of nearly 2,223.5 million in 2020, with an annual growth rate of 9.2% since 2015. The market will grow from $2,223,5 million in 2020 to $3,362,1 million by 2025 at a rate of 8.6%. The market is expected to grow at a CAGR of 6.2% from 2025 and reach 447.7 million in 2030.Growth in the historic period resulted in increased healthcare spending, increased funding, accelerated demand for In the historical period, the lack of awareness on induced pluripotent stem cells negatively affected growth.The progress was focused on increasing prevalence of chronic diseases, growth genomic projects, development of iPSC models, increasing funding and increasing The induced pluripotent stem cell market is segmented by application into drug discovery and toxicity studies, research, cell & gene therapy and the regenerative medicine. The drug discovery and toxicity study was the largest segment of the induced pluripotent stem cell (PSC) market segmented by application, accounting for 48,7% of total in 2020. The induced pluripotent stem cell (iPSC) market is segmented by application, with a CAGR of 9.82% between 2020 and 2025. The research laboratory was the largest segment of the induced pluripotent stem cell (SCM) market segmented by end-user, accounting for 68.5% of 2020 total. The hospitals segment will be the fastest growing segment of the induced pluripotent stem cell (iPSC) market segmented by end-user, at a CAGR of 9.3% during 2020-2025. In addition, The fibroblasts were the largest segment of the induced pluripotent stem cell (IPSC) market segmented by derived cell type, accounting for 33.0% of 2020 total. Moreover, the second segment is expected to be the fastest growing segment of the induced pluripotent stem cell (iPSC) market, segmented by derived cell type, at a rate of 10.0% in 2020 The top ten competitors in the market made up up to 26 percent of the total market in 2020. In the fibroblasts segment, the most competitive opportunities will arise in the spread of the cell type induced pluripotent stem cells (PPP) market by 2025. The biggest opportunity in the pluripotent stem cell (IPSC) market segmented by end-users will arise in hospitals segment, which will gain $393.0 million of global annual sales by 2025. The most exciting opportunities in the induced pluripotent stem cell (PVC) market segmented by application will be the segment of the drug discovery and toxicity studies segment, which will gain $520.3 million of global annual sales The most significant amount of revenue in the USA will be $332,6 million in induced pluripotent stem cell (PSC) market size. The key topic covered: 1. It is the result of Induced Pluripotent Stem Cells (iPSC) Executive Summary of an Induction induced Plupotente Stembrella (IPSD) Executive Summary Summary Of 2. Table of Contents Table Table the contents 3. Table of figures, figures list, list of Figures list. 4. Tables for Table List of Table Table. 5 Report Structure 6 o'clock, Introduction 6.1. Segmentation by Geography 6. Segmentation by derived cell type6.3. Segmentation by Application6.4. Segmentation By End-Use Industry Segmentsation by Enduser Industrial Services Segementation. 7 o'clock Characteristics of Market Characterizations in Induced Pluripotent Stem Cell (iPSC) Inductions Market Caractristiques of Input and Indued Pleuri Potent Stim Cells 7.1. Segmentation according derived cell type7.1.1. Hepatocytes7.1.2. Fibroblasts7.1.3. Keratinocytes184.108.40.206. Kerateateinoocyte. Amniotic7.1.5. Other7.2. Segmentation by Application7.2.1. Academic Research7.2.2. Drug Discovery Toxicity Studies7.2.3. Regenerative Medicine 7.2.4. The therapy of the cells is a procedure for cell therapy and synthesis. Segmentation By End-User7.3.1. Hospitals7.3.2. Research Laboratories are the Laborators. 8. The Induction of Pluripotent Stem Cell (iPSC) Trends in the iSiD-induced CNST - Trend Trend Strategies for inducing apfluent stem cell ( 8.1. Use of pheromacoes in the treatment of Parkinson's disease (8.2). Strategic collaborations Partnerships8.3. Development of induced pluripotent stem cell cells with iPSC-Derived NK cells8.4. Demand for induced pluripotent stem cells (iPSC) For Cell Therapy8.5. Expansion and improvements in drug research8.6. Use of pluripotent stem cells in treatment of type 1 diabetes. 9. Covid-19 on iPSC Market induced pluripotent stem cells (induce) Effort of Covny-Night On Induceed Pluri Potent Stem Cell (iP 9.1. Impact on demand for induced pluripotent stem cells9.2. Increasing Research Development Activities 10. Global Induced Pluripotent Stem Cell (PPPS) Size Growth Growth from the Global Scale Growth Scaling Growth (Global Indued) Globalized pluri-potente Steme Cells (IPS 10.1. Market size 10,2 o'clock. Historic Market Growth, 2015 - 2020, Value ($ Million)10.2.1. The Market has the potential for a market growth of 2015 - 202010.2.2. The market is restricted from 2015 - 202010.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)10.3.1. Drivers of the Market 2020 - 202510.3.2. The Market Limits 2020 - 2025. 11. Global Induced Pluripotent Stem Cell (iPSC) Segmentation of Segmented Cells (Seminated Cell) (Global Input) and Selected Cell - Global (Integrated Induction) 11.1 Market, Segmentation by Derived Cell Type, Historic Forecast 2015 - 2020, 2025F, 2030F and Value ($ Million)11.1.1. Fibroblasts 11.1.2. Hepatocytes 11.1.3. Keratinocytes11.1.4. Amniotic11.1.5. Others11.2. Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F Value ($ Million)11.2.1. Drug Discovery & Toxicity Studies 11.2.2. Academic Research 11.2.3. Cell & Gene Therapy 11.2.4. Regenerative medicine.11.3. The Global Induced Pluripotent Stem Cell (PLP) Market, Segmentation By End-Use Industry, Historic Forecast 2015-2020, 2025F, 2030F value ($ Million)11.3.1. Research Laboratories 11.3.2. Hospitals are located in the same area. Companies mentioned are mentionees.
- Fujifilm Holding Corporation is a Fuji-film-owned company.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- ViaCyte Vioacytoe el Vizozne, una yavnias.
- The Fate Therapeutics of Fats are a therapy for fat-reaction.
For more information about this report, go to https://www.researchandmarkets.com/r/6e61hk. For further information, visit https:www4resources/.fr.
Media Contact Contact:
+1-917-300-0470 For U.S./CAN Toll Free Call -1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U-S Fax: 646-60
Research and Markets SOURCE SEARCE.